Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.2.0.727
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Joint Share Ownership Plan Awards [Member]
Common Stock [Member]
Joint Share Ownership Plan Awards [Member]
Additional Paid In Capital [Member]
Joint Share Ownership Plan Awards [Member]
Treasury Stock [Member]
Joint Share Ownership Plan Awards [Member]
Common Stock [Member]
Symbio Tec Gmbh [Member]
Common Stock [Member]
Serum Institute Of India Limited [Member]
Common Stock [Member]
Additional Paid In Capital [Member]
Symbio Tec Gmbh [Member]
Additional Paid In Capital [Member]
Serum Institute Of India Limited [Member]
Additional Paid In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income [Member]
Treasury Stock [Member]
Symbio Tec Gmbh [Member]
Serum Institute Of India Limited [Member]
Total
Beginning Balance at Dec. 31, 2011             $ 922,343     $ 58,124,439 $ (43,399,413) $ (254,903) $ (588,662)     $ 14,803,804
Beginning Balance, Shares at Dec. 31, 2011             92,234,321                  
Exercise of stock options             $ 195     514           709
Exercise of stock options, Shares             19,535                  
Issuance of common stock $ 89,863 $ 4,664,406 $ (4,692,518) $ 61,751 $ 256,000 $ 36,800   $ 9,002,326 $ 1,435,355         $ 9,258,326 $ 1,472,155  
Issuance of common stock, Shares 8,986,281       25,600,000 3,680,000                    
Share-based compensation                   339,780           339,780
Net loss                     (6,328,340)         (6,328,340)
Foreign currency translation                       1,170,501       1,170,501
Ending Balance at Dec. 31, 2012             $ 1,305,201     73,566,820 (49,727,753) 915,598 (5,281,180)     20,778,686
Ending Balance, Shares at Dec. 31, 2012             130,520,137                  
Exercise of stock options             $ 554     1,536           2,090
Exercise of stock options, Shares             55,379                  
Share-based compensation                   431,504           431,504
Net loss                     (8,579,246)         (8,579,246)
Foreign currency translation                       (15,344)       (15,344)
Ending Balance at Dec. 31, 2013             $ 1,305,755     $ 73,999,860 $ (58,306,999) $ 900,254 $ (5,281,180)     $ 12,617,690
Ending Balance, Shares at Dec. 31, 2013             130,575,516